This report is intended to contribute to an understanding of the natural morbidity of patients with chronic rheumatic heart disease in the third, fourth, and fifth decades of life. The (lata should prove useful in a consideration of the criteria for surgical intervention.
T1HE recent emphasis on early surgical intervention for patients with chronic rheumatic valvular disease has made the need for basic data concerning the natural history of this conditioii of practical importance.
Data regarding the natural morbidity of patients with chronic rheumatic heart disease in the third, fourth, and fifth decades of life are presented. This information should prove useful in evaluating the effects of surgical intervention on the natural morbidity and mortality of the disease.1-3 METHODS AND MATERIALS Of 757 adult patients with rheumatic hcart dlisease analyzed in the previous stuldy on survivorship,' 385 patients were examined and followed by the authors personally (luring 1953 to 1955 . All of these patients have been uncler medlical supervision in the same cardiac clinic since childhood as part of a long-term follow-up study. They were therefore not comparable with a group of adults attending a cardiac clinic because of cardliopulmonary symptoms. There were 160 males and 225 females, and this sex ratio held true for the subgroups studied. All patients were examined an average of 6 times in the 3-year period. Patients with cardiopulmonary symptoms were seen more frequently. On is.
tients are included in functional classification II because of persistent but nonprogressive cardiopulmonary symptoms of mild to moderate degree. The murmurs were persistent in all. There were 4 patients in the third decade of life, 5 in the fourth, and 4 in the fifth. All well. One womani developed congestive heart failure, and another developed chronic atrial fibrillation during the first pregnancy but withstood her second pregnancy wvell. In a third patient a mitral diastolic murmur that had temporarily regressed, reappeared with her second pregnancy and persisted. These 13 patients, according to most observers, would be considered probable candidates for surgery.
Functional Classification III. Ten patients had progressive cardiopulmonary symptoms. rThe majority were in the fourth and fifth decades of life. All had persistent murmurs. All but had marked cardiac enlargemenit. Nearly every patient had electrocardiographic evidence of left ventricular and right ventricular hypertrophy, and atrial involvement. After the age of 20, 1 patient experienced active carditis. Five had atrial fibrillation. All patients had reduction in vital capacity, most of them marked. Four women experienced 10 pregnancies. One of these developed a concomitant subacute bacterial endocarditis and another 2 patients developed persistent hypertensive cardiovascular disease after pregnancy with a subsequent increase in cardiopulmonary symptoms. Several of these patients would be considered candidates by many surgeons.
Functional Classification I V. Four patients had extreme cardiopulmonary symptoms. There wvas 1 patient in the third decade of life, 2 in the fourth, and 1 in the fifth. Three patients had marked cardiac enlargement, marked reduction in vital capacity and intractable congestive heart failure; 1 of these had associated tricuspid insufficiency. The remaining patient had idiopathic pulmonary fibrosis and insufficiency. None In 60 instances of a change in symptomatic status, factors were identified that might have been causally related to the development of subjective complaints of dyspnea associated with the objective findings of decreased vital capacity, increased heart size, or congestive heart failure. Among these 60 instances of changed morbidity, decreasing vital capacity, further cardiac chamber enlargement, and congestive heart failure either as an episode or continuous and intractable, characterized the course. In 8 instances active carditis was responsible; in all additional 2 instances, active carditis may have occurred when these patients were not under our medical supervision. In1 14 instances the onset of atrial fibrillation attended the changed symptomatic status. In 6 instances there was progressive deterioration from an asymptomatic state to functional classification IV, due to cirrhosis in one, chronic pulmonary disease in a second, and the development of hypertensive or arteriosclerotic heart disease ill 4. In 22, other factors were identified with a change in functional classification. These included pneumonia ill 15, healed subacute bacterial endocarditis in 3, and thromboembolism in 4. Whether there was an associated subacute carditis in some of these patients could not be ascertaiiied. In1 8 instances pregnancy was associated with a change ill morbidity.
There were 11 instances of change in clinical status in which no causal factor could be identified to explain the change ill functional classification. In 3, it represented a change from class I to class II; in 4, a change from class II to III, and in 4 a change from class II or III to class IV. All of these patients had marked cardiac enlargement with mitral stenosis and insufficiency and aortic stenosis and insufficiency that were present since age 20. It is possible that changes in symptomatic status were related to the progressive influence upon the circulation of chronic valvular disease. However, the extent of myocardial damage and the presence of unrecognized carditis must be considered.
Further information pertinent to the study of the natural morbidity of rheumatic heart disease was available from the records of 45 of 53 patients who died of cardiac causes after surviving to the age of 20 years or more.
There were 14 patients with mitral stenosis whose records were suitable for analysis; 77 were ill the third decade of life, 4 in the fourth, and 3 in the fifth decade. Of those ill the third decade, all were asymptomatic until within 1 year or less of death. F,ive had moderate cardiac enlargement. In 5, death was sudden, and in 2 of these pregnancy was a complicating feature. Two patients with marked cardiac enlargement became symptomatic with the onset of atrial fibrillation. Of the 4 patients in the fourth decade of life, all had cardiopulmonary symptoms for a period of 2 to 7 years. All but 1 had marked cardiac enlargement. Two had had mitral valve surgery, one of whom survived .3 years but had no change in functional status, and the other remained in intractable congestive heart failure for the year following surgery. Of the 3 patients in the fifth decade of life, all had marked cardiac enlargement and atrial fibrillation with cardiopulmonary symptoms for 2 to 6 years before death. Two patients had had valvulotomy; one survived for 2 years without improvement, and the other succumbed after 4 years with pulmonary embolism.
There were :31 patients with aortic and mitral valve disease. Nine of these had demonstrable carditis as the terminal event; 4 of these were asymptomatic prior to their terminal event for a period of 2 to 9 years, 3 had atrial fibrillation, and 2 had severe intractable congestive heart failure for 3 and 5 years respectively before death. Of the remaining 22 patients who died, 9 were in the third decade of life, 12 in the fourth, and 1 in the fifth decade. In the third decade, all but 1 patient had marked cardiac enlargement, and 5 had atrial fibrillation. One patient sustained sudden death from pulmonary embolism, and 2 had a preceding subacute bacterial endocarditis. They had been asymptomatic for 1 to 9 years. In the fourth decade of life, all but 1 of the 12 patients had marked cardiac enlargement, and 10 had atrial fibrillation. The majority were asymptomatic for a period of 6 to 15 years. Five patients had a sudden death, presumably embolic in nature. The 1 patient in the fifth decade of life, with marked cardiac enlargement and atrial fibrillation, who had been asymptomatic for 19 years, had nonprogressive symptoms for an additional 4 years and then experienced pulmonary edema within 6 months of her terminal episode, which was associated with bronchopneumonia.
It is of interest that of the 45 patients whose death was attributed to cardiac causes, carditis, fibrillation, pulmonary embolism, and pneumonia were identified as common factors that appeared to induce the terminal event. Comparison of fluoroscopic estimate of cardiac enlargement and heart weight for 22 patients (per cent excess of heart weight over expected heart weight for sex and body weight).
Autopsies were performed in 25 of the 78 deaths. Six autopsied patients had carditis clinically; it was confirmed in all. No other instances of carditis were found at autopsy. In 22, death was directly attributable to rheumatic heart disease or its complications. In all instances of mitral stenosis the clinical diagnosis was confirmed pathologically and no false positive diagnoses were made clinically. A failure in clinical diagnoses was noted in 2 instances of aortic insufficiency, 2 of aortic stenosis, and 4 of tricuspid stenosis. Two patients had mitral insufficiency alone, both of whom died of noncardiac causes. There were 9 patients with mitral stenosis and insufficiency alone, and 15 with mitral and aortic disease; 5 of the latter group had tricuspid insufficiency.
These autopsies were performed between the years 1937 to 1954, and only 19 were performed at the New York Hospital. In 22, data were available with reference to heart weight, and in 21 direct measurements were made of the thicknesses of both ventricles. Figure 2 shows a good correlation between the fluoroscopic estimate of over-all heart size and the per cent in excess of actual, over expected, heart weight when corrected for body weight and sex.6 The heart weights ranged between 270 and 1,010 Gm. Among 21 patients with left ventricular enlargement fluoroscopically, hypertrophy was noted in 16 at autopsy. In 11 patients enlargement of the right ventricle was demonstrated fluoroscopically and in 6 of these hypertrophy was reported pathologically.
Ten patients had electrocardiograms demon-
strating atrial fibrillation, all of whom had fluoroscopic evidence and 7 of whom had autopsy evidence of left atrial enlargement. Inasmuch as the majority of these patients died prior to the use of unipolar leads, no statement can be made as to the relationship between electrocardiographic and postmortem evidence of specific chamber hypertrophy.
DISCUSSION
It is significant that 89 per cent of the 385 patients with rheumatic heart disease, ranging in age from 20 to 49 years, who were under our medical supervision were asymptomatic. It is to be recalled that the anatomic diagnosis was established in the majority by age 20, and that these patients were under observation because of a long-term follow-up. Of interest is the observation that one half of these patients had simple mitral insufficiency without marked cardiac enlargement. None of these asymptomatic patients would, as of the present time, be considered candidates for cardiac surgery.
Of particular importance is the finding that only 45 The factors found responsible for morbidity and mortality after the age of 20 were active carditis, atrial fibrillation, bacterial endocarditis, pregnancy, pneumonia, and embolic phenomenia.
1'atients who experienced cardiopulmonary symptoms had beeni asymptomatic for periods of 2 to 24 years after age 20, with an average of 10.5 years. Patients who died of cardiac causes had been asymptomatic for 1 to 20 years before the terminal event.
Cardiac chamber enlargement did not appear to progress with advancing age per se, irrespective of the type of valvular deformity. Confirnationi of fluoroscopic estimate of over-all heart and chamber enlargement was obtained on postmortem examination.
The majority of patients with rheumatic heart disease who survivied to the age of 20 to 49 years were in functional classification I. The majority of patients with mitral stenosis and insufficiency alone or with associated aortic disease who had markedly enlarged hearts were in functional classification II, III, or IV.
The residual cardiac damage sustained iii the first 2 decades of life, particularly the extent of cardiac enlargement,, appears to be the major factor influencing morbidity and mortality in the third, fourth, and fifth decades. The Natural History of Rheumatic Heart Disease in the Third, Fourth, and
